Faraday Pharmaceuticals

faradaypharma.com

Faraday Pharmaceuticals developed iodide-based therapies for medical applications and conducted clinical trials in STEMI patients.

Facts

HQ
Seattle, Washington, US
Sectors
Pharmaceutical Manufacturing
Founded
2014
Type
Corporation Seattle business license
Employees
11–50
Registered name
Faraday Pharmaceuticals Seattle business license
Members see funding amounts.
.

Is this your organization? Claim it

Proniras launches in Seattle to develop Eli Lilly’s tezampanel, wins $89.5M BARDA contract

Proniras Corporation launched in Seattle to develop tezampanel, a seizure drug originally created by Eli Lilly, and secured an $89.5 million BARDA contract contingent on development milestones. The company also received undisclosed launch funding from several investors, will be led by co-founder and CSO Chris Toombs, and plans to explore tezampanel as both a seizure therapy and a nerve-agent antidote.

See all 4 stories, episodes and videos about Faraday Pharmaceuticals.

Online